Subclinical Hypothyroidism Presenting as Myxedema Coma: Case Report and Literature Review
Open Access
- 1 June 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25588
Abstract
Myxedema coma is a medical emergency with a high mortality rate. Patients with hypothyroidism may develop myxedema coma if left untreated, although quite rare nowadays owing to regular TSH (thyroid stimulating hormone) monitoring. We present the case of a patient with a known history of subclinical hypothyroidism, defined by normal free T4 (thyroxine) and high TSH, who was found to be in myxedema coma. Clinically, the patient was found to be lethargic, bradycardic, and hypothermic, and in the background of high TSH, myxedema coma was suspected. The patient was admitted to the ICU (Intensive Care Unit) and initially treated with intravenous (IV) hydrocortisone for possible concomitant adrenal insufficiency. This was followed by treatment with IV levothyroxine.Keywords
This publication has 16 references indexed in Scilit:
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone ReplacementThyroid®, 2014
- A Diagnostic Scoring System for Myxedema ComaEndocrine Practice, 2014
- Myxedema Coma in a Patient with Subclinical HypothyroidismThyroid®, 2011
- Myxedema Coma: A New Look into an Old CrisisJournal of Thyroid Research, 2011
- The Clinical Significance of Subclinical Thyroid DysfunctionEndocrine Reviews, 2007
- Myxedema ComaJournal of Intensive Care Medicine, 2007
- HypothyroidismThe Lancet, 2004
- Mechanism of the Heparin-Induced Increase in the Concentration of Free Thyroxine in Plasma*The Journal of Clinical Endocrinology & Metabolism, 1987
- Thyroid Storm and Myxedema ComaMedical Clinics of North America, 1985
- Treatment of Myxedema Coma With Intravenous ThyroxineArchives of internal medicine (1960), 1964